Journal of Biological Chemistry · 2004 · 98 citations · 49 references
Life SciencesCell BiologyMolecular BiologyEndocytosisEnzymologyProtein FoldingEndomembrane SystemLysosomal BiochemistryLysosomal TraffickingMembrane ProteinsProteolytic EnzymesProteolytic ProcessingLysosomal Degradation PathwaysLysosomal Enzyme SortingLysosomal Membrane ProteinsLysosomal ProteasesLysosomal Protein SortingLysosomal ProteolysisMembrane Protein TraffickingTransmembrane Proteins
Variant late infantile neuronal ceroid lipofuscinosis, a lysosomal storage disorder characterized by progressive mental deterioration and blindness, is caused by mutations in a polytopic membrane protein (CLN6) with unknown intracellular localization and function. In this study, transient transfection of BHK21 cells with CLN6 cDNA and immunoblot analysis using peptide-specific CLN6 antibodies demonstrated the expression of a ∼27-kDa protein that does not undergo proteolytic processing. Cross-linking experiments revealed the presence of CLN6 dimers. Using double immunofluorescence microscopy, epitope-tagged CLN6 was shown to be retained in the endoplasmic reticulum (ER) with no colocalization with the cis-Golgi or lysosomal markers. The translocation into the ER and proper folding were confirmed by the N-linked glycosylation of a mutant CLN6 polypeptide. Pulse-chase labeling of fibroblasts from CLN6 patients and from sheep (OCL6) and mouse (nclf) models of the disease followed by immunoprecipitation of cathepsin D indicated that neither the synthesis, sorting nor the proteolytic processing of this lysosomal enzyme was affected in CLN6-defective cells. However, the degradation of the endocytosed index protein arylsulfatase A was strongly reduced in all of the mutant CLN6 cell lines compared with controls. These data suggest that defects in the ER-resident CLN6 protein lead to lysosomal dysfunctions, which may result in lysosomal accumulation of storage material. Variant late infantile neuronal ceroid lipofuscinosis, a lysosomal storage disorder characterized by progressive mental deterioration and blindness, is caused by mutations in a polytopic membrane protein (CLN6) with unknown intracellular localization and function. In this study, transient transfection of BHK21 cells with CLN6 cDNA and immunoblot analysis using peptide-specific CLN6 antibodies demonstrated the expression of a ∼27-kDa protein that does not undergo proteolytic processing. Cross-linking experiments revealed the presence of CLN6 dimers. Using double immunofluorescence microscopy, epitope-tagged CLN6 was shown to be retained in the endoplasmic reticulum (ER) with no colocalization with the cis-Golgi or lysosomal markers. The translocation into the ER and proper folding were confirmed by the N-linked glycosylation of a mutant CLN6 polypeptide. Pulse-chase labeling of fibroblasts from CLN6 patients and from sheep (OCL6) and mouse (nclf) models of the disease followed by immunoprecipitation of cathepsin D indicated that neither the synthesis, sorting nor the proteolytic processing of this lysosomal enzyme was affected in CLN6-defective cells. However, the degradation of the endocytosed index protein arylsulfatase A was strongly reduced in all of the mutant CLN6 cell lines compared with controls. These data suggest that defects in the ER-resident CLN6 protein lead to lysosomal dysfunctions, which may result in lysosomal accumulation of storage material. Neuronal ceroid lipofuscinoses (NCLs), 1The abbreviations used are: NCL, neuronal ceroid lipofuscinosis; MPR, mannose 6-phosphate receptor; ER, endoplasmic reticulum; OCL6, ovine NCL; MESNA, 2-mercaptoethanesulfonic acid; BS3, bis(sulfosuccinimidyl) suberate; DSS, disuccinimidylsuberate; ASA, arylsulfatase A; CtsD, cathepsin D; PDI, protein-disulfide isomerase; endo H, endoglycosidase H; MES, 4-morpholineethanesulfonic acid; PNGase F, peptide N-glycosidase F. also collectively called Batten disease, are a group of autosomal recessively inherited neurodegenerative diseases that affect both children and adults. The clinical features include loss of vision, seizures, and mental and motor deterioration. Depending on the affected gene, the clinical signs become visible at various developmental stages (1Goebel H.H. Schochet S.S. Jaynes M. Bruck W. Kohlschütter A. Hentati F. Mol. Genet. Metab. 1999; 66: 367-372Crossref PubMed Scopus (30) Google Scholar). Currently, eight forms of human NCLs (CLN1–8) can be differentiated for which six underlying genes have been identified (2Haltia M. J. Neuropathol. Exp. Neurol. 2003; 62: 1-13Crossref PubMed Scopus (226) Google Scholar). CLN1 and CLN2 encode for soluble lysosomal enzymes, palmitoyl protein thioesterase 1 and tripeptidylpeptidase 1, respectively (3Hellsten E. Vesa J. Olkkonen V.M. Jalanko A. Peltonen L. EMBO J. 1996; 15: 5240-5245Crossref PubMed Scopus (153) Google Scholar, 4Vines D. Warburton M.J. FEBS Lett. 1999; 443: 131-135Crossref PubMed Scopus (142) Google Scholar, 5Lin L. Sohar I. Lackland H. Lobel P. J. Biol. Chem. 2001; 276: 2249-2255Abstract Full Text Full Text PDF PubMed Scopus (115) Google Scholar). CLN3, CLN5, CLN6, and CLN8 represent transmembrane proteins of still unknown function (6Janes R.W. Munroe P.B. Mitchison H.M. Gardiner R.M. Mole S.E. Wallace B.A. FEBS Lett. 1996; 399: 75-77Crossref PubMed Scopus (69) Google Scholar, 7Savukoski M. Klockars T. Holmberg V. Santavuori P. Lander E.S. Peltonen L. Science. 1998; 277: 1802-1805Google Scholar, 8Ranta S. Zhang Y. Ross B. Lonka L. Takkunen E. Messer A. Sharp J. Wheeler R. Kusumi K. Mole S. Liu W. Soares M.B. Bonaldo M.F. Hirvasniemi A. de la Chapelle A. Gilliam T.C. Lehesjoki A.E. Nat. Genet. 1999; 23: 233-236Crossref PubMed Scopus (258) Google Scholar, 9Wheeler R.B. Sharp J.D. Schultz R.A. Joslin J.M. Williams R.E. Mole S.E. Am. J. Hum. Genet. 2002; 70: 537-542Abstract Full Text Full Text PDF PubMed Scopus (153) Google Scholar, 10Gao H. Boustany R.M. Espinola J.A. Cotman S.L. Srinidhi L. Antonellis K.A. Gillis T. Qin X. Liu S. Donahue L.R. Bronson R.T. Faust J.R. Stout D. Haines J.L. Lerner T.J. MacDonald M.E. Am. J. Hum. Genet. 2002; 70: 324-335Abstract Full Text Full Text PDF PubMed Scopus (174) Google Scholar). Although the nature of these CLN genes differs, defects in most of them lead to massive storage of autofluorescent material in lysosomes that has been identified as the subunit c of the mitochondrial ATP synthase (2Haltia M. J. Neuropathol. Exp. Neurol. 2003; 62: 1-13Crossref PubMed Scopus (226) Google Scholar, 11Palmer D.N. Fearnley I.M. Walker J.E. Hall N.A. Lake B.D. Wolfe L.S. Haltia M. Martinus R.D. Jolly R.D. Am. J. Med. Genet. 1992; 42: 561-567Crossref PubMed Scopus (326) Google Scholar, 12Palmer D.N. Jolly R.D. van Mil H.C. Tyynelä J. Westlake V.J. Neuropediatrics. 1997; 28: 45-48Crossref PubMed Scopus (66) Google Scholar). Newly synthesized palmitoyl protein thioesterase 1 and tripeptidylpeptidase 1 are transported to the lysosome in a Man-6-P-dependent manner (3Hellsten E. Vesa J. Olkkonen V.M. Jalanko A. Peltonen L. EMBO J. 1996; 15: 5240-5245Crossref PubMed Scopus (153) Google Scholar, 5Lin L. Sohar I. Lackland H. Lobel P. J. Biol. Chem. 2001; 276: 2249-2255Abstract Full Text Full Text PDF PubMed Scopus (115) Google Scholar). Binding to Man-6-P-specific receptors, MPR46 and MPR300, allows the segregation from the secretory pathway and transport from the trans-Golgi-network to the endosomal compartment. Because of the low pH, the receptor-ligand complexes dissociate and the enzymes are delivered to the lysosome. Soluble enzymes that escape binding to the MPR in the trans-Golgi network are secreted but can be partially endocytosed after binding to MPR localized at the cell surface and transported to the lysosome (13Braulke T. Lloyd J.B. Mason R.W. Subcellular Biochemistry: Biology of the Lysosome. 27. Plenum Press, New York1996: 15-49Google Scholar). CLN3, CLN5, and CLN8 have been localized in lysosomes and the endoplasmic reticulum (ER)/ER-Golgi-intermediate compartment, respectively (14Järvelä I. Lehtovirta M. Tikknen R. Kyttälä A. Jalanko A. Hum. Mol. Genet. 1999; 8: 1091-1098Crossref PubMed Scopus (105) Google Scholar, 15Isosomppi J. Vesa J. Jalanko A. Peltonen L. Hum. Mol. Genet. 2002; 11: 885-891Crossref PubMed Scopus (104) Google Scholar, 16Lonka L. Kyttälä A. Ranta S. Jalanko A. Lehesjoki A.-E. Hum. Mol. Genet. 2000; 9: 1691-1697Crossref PubMed Scopus (96) Google Scholar). The subcellular localization of CLN6 is not known. The transport of lysosomal membrane proteins requires tyrosine- or dileucine-based sorting signals (17Bonifacino J.S. Dell'Angelica E.C. J. Cell Biol. 1999; 145: 923-926Crossref PubMed Scopus (370) Google Scholar). Recently, lysosomal targeting motifs have been identified in CLN3 protein (18Kyttäla A. Ihrke G. Vesa J. Schell M.J. Luzio J.P. Mol. Biol. Cell. 2004; 15: 1313-1323Crossref PubMed Scopus (93) Google Scholar), whereas the localization of CLN8 in the ER is mediated by a KKXX-ER-retrieval signal (16Lonka L. Kyttälä A. Ranta S. Jalanko A. Lehesjoki A.-E. Hum. Mol. Genet. 2000; 9: 1691-1697Crossref PubMed Scopus (96) Google Scholar). The CLN6 gene encodes a highly conserved 311 amino acid protein with six to seven predicted membrane-spanning domains. The deduced amino acid sequence contains no putative N-glycosylation sites or classical lysosomal sorting signals. Furthermore, no sequence homologies to other proteins have been described (9Wheeler R.B. Sharp J.D. Schultz R.A. Joslin J.M. Williams R.E. Mole S.E. Am. J. Hum. Genet. 2002; 70: 537-542Abstract Full Text Full Text PDF PubMed Scopus (153) Google Scholar, 10Gao H. Boustany R.M. Espinola J.A. Cotman S.L. Srinidhi L. Antonellis K.A. Gillis T. Qin X. Liu S. Donahue L.R. Bronson R.T. Faust J.R. Stout D. Haines J.L. Lerner T.J. MacDonald M.E. Am. J. Hum. Genet. 2002; 70: 324-335Abstract Full Text Full Text PDF PubMed Scopus (174) Google Scholar). Various mutations of the CLN6 gene have been identified, leading to the variant late infantile form of NCL (9Wheeler R.B. Sharp J.D. Schultz R.A. Joslin J.M. Williams R.E. Mole S.E. Am. J. Hum. Genet. 2002; 70: 537-542Abstract Full Text Full Text PDF PubMed Scopus (153) Google Scholar, 10Gao H. Boustany R.M. Espinola J.A. Cotman S.L. Srinidhi L. Antonellis K.A. Gillis T. Qin X. Liu S. Donahue L.R. Bronson R.T. Faust J.R. Stout D. Haines J.L. Lerner T.J. MacDonald M.E. Am. J. Hum. Genet. 2002; 70: 324-335Abstract Full Text Full Text PDF PubMed Scopus (174) Google Scholar, 19Sharp J.D. Wheeler R.B. Parker K.A. Gardiner R.M. Williams R.E. Mole S.E. Hum. Mutat. 2003; 22: 35-42Crossref PubMed Scopus (65) Google Scholar, 20Teixeira C. Guimaraes A. Bessa C. Ferreira M.J. Lopes L. Pinto E. Pinto R. Boustany R.M. Sa Miranda M.C. Ribeiro M.G. J. Neurol. 2003; 250: 661-667Crossref PubMed Scopus (33) Google Scholar, 21Teixeira C.A. Espinola J. Huo L. Kohlschütter J. Persaud Sawin D.A. Minassian B. Bessa C.J. Guimaraes A. Stephan D.A. Sa Miranda M.C. MacDonald M.E. Ribeiro M.G. Boustany R.M. Hum. Mutat. 2003; 21: 502-508Crossref PubMed Scopus (35) Google Scholar). Naturally occurring NCLs in South Hampshire and Merino sheep (OCL6) and nclf mice have been localized to CLN6 (22Jolly R.D. Walkley S.U. Mol. Genet. Metab. 1999; 66: 376-380Crossref PubMed Scopus (16) Google Scholar, 23Bronson R.T. Donahue L.R. Johnson K.R. Tanner A. Lane P.W. Faust J.R. Am. J. Med. Genet. 1998; 77: 289-297Crossref PubMed Scopus (114) Google Scholar, 24Cook R.W. Jolly R.D. Palmer D.N. Tammen I. Broom M.F. McKinnon R. Aust. Vet. J. 2002; 80: 292-297Crossref PubMed Scopus (44) Google Scholar). The severe and progressive neurodegeneration of the cerebral cortex is accompanied by astrocytosis and elevated expression of the radical scavenger protein Mn-SOD (24Cook R.W. Jolly R.D. Palmer D.N. Tammen I. Broom M.F. McKinnon R. Aust. Vet. J. 2002; 80: 292-297Crossref PubMed Scopus (44) Google Scholar, 25Heine C. Tyynelä J. Cooper J.D. Palmer D.N. Elleder M. Kohlschütter A. Braulke T. Biochem. J. 2003; 376: 369-376Crossref PubMed Scopus (29) Google Scholar). Furthermore, differences in the fatty acid profiles of brain phosphatidylethanolamine have been observed in OCL6-affected sheep (26Palmer D.N. Husbands D.R. Jolly R.D. Biochim. Biophys. Acta. 1985; 834: 159-163Crossref PubMed Scopus (20) Google Scholar). In this study, we expressed human CLN6 in BHK21 cells to investigate its subcellular localization. Furthermore, the transport of lysosomal enzymes via the biosynthetic and endocytic pathway was examined in fibroblasts from CLN6 patients, OCL6, and nclf mice. The data indicate that CLN6 is an ER-resident protein. Materials—Sodium 125I (>15 Ci/mg iodine), [35S]methionine (>1000 Ci/mmol), and Rainbow™-colored protein molecular mass marker were obtained from Amersham Biosciences. Opti-MEM, LipofectAMINE™ 2000, and antibiotics (penicillin/streptomycin) were purchased from Invitrogen. Protease inhibitor mixture (P-2714), transferrin, protein A-agarose, 2-mercaptoethanesulfonic acid (MESNA), and Man-6-P were obtained from Sigma. Bradford reagent and Trans-Blot nitrocellulose membrane (0.2 μm) were purchased from Bio-Rad, and bis(sulfosuccinimidyl)suberate (BS3), disuccinimidylsuberate (DSS), sulfosuccinimidyl-2-(biotinamido)ethyl-1,3-dithio propionate, and IODO-GEN® were obtained from Pierce. Restriction endonucleases, T4 DNA ligase, and other molecular biology reagents were from Invitrogen, New England Biolabs, Qiagen, and Stratagene (La Jolla, CA). Recombinant human arylsulfatase A (ASA) purified from ASA-overexpressing mouse embryonic fibroblasts deficient for MPRs (27Dierks T. Schmidt B. von Figura K. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 11963-11968Crossref PubMed Scopus (112) Google Scholar) was kindly provided by Dr. T. Dierks (University of Göttingen, Göttingen, Germany). CLN6 Cloning—Full-length CLN6-cDNA was amplified using forward primer 5′-CGGGATCCGCGATGGAGGCGACGCGGAGG-3′ and reverse primer 5′-CCCAAGCTTGGGGTGCCGACTGCTGACGTG-3′ with IMAGE clone IMAG p998E179643 as template in vector pCMVSPORT6. The was with the of vector A into The CLN6 was amplified with the reverse primer expression of for were amplified with and and into sites of vector The was by using the and the and of the were to mutations and to of antibodies mouse and human purified from mouse and human and human were in A. J. Biol. Chem. Full Text PDF PubMed Google Scholar, C. B. M. Braulke T. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus (96) Google Scholar, M. B. M. K. Schmidt B. J. Braulke T. 1997; PubMed Scopus Google Scholar). The was obtained from CA). The a from J. was in cell lines purchased from and the protein-disulfide was purchased from The was in the peptide and and purified by on a and a protein and were obtained from and the was from and of mice were obtained from The mice as controls. The were and to in of the were from of mice as described B. W. P. C. Braulke T. FEBS Lett. 2002; PubMed Scopus Google Scholar). Cell and Cell fibroblasts from affected South Hampshire and sheep as as from CLN6 patients were the as described C. Tyynelä J. Cooper J.D. Palmer D.N. Elleder M. Kohlschütter A. Braulke T. Biochem. J. 2003; 376: 369-376Crossref PubMed Scopus (29) Google Scholar). The cells were in and in a at BHK21 cells were the in and as described S. S. A. Tyynelä J. Braulke T. Biochem. J. 2003; PubMed Scopus Google Scholar). cells were with A vector and were with [35S]methionine for 1 followed by a for the indicated was from cell and as described U. S. V. K. Braulke T. Biochem. J. 2002; PubMed Scopus Google Scholar) and by and Cell and surface proteins were with at as described C. von Figura K. P. J. Cell Sci. 2001; PubMed Google Scholar). the cells were in the presence or of in 1 and followed by immunoprecipitation of from cell as described C. B. M. Braulke T. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus (96) Google Scholar). of was examined as described U. S. V. K. Braulke T. Biochem. J. 2002; PubMed Scopus Google Scholar). The was after of at were and cell was by an H. von Figura K. Braulke T. Biochem. J. 1992; PubMed Scopus Google Scholar). were and by and and proteins from and cells were by to nitrocellulose and examined for and as described C. Tyynelä J. Cooper J.D. Palmer D.N. Elleder M. Kohlschütter A. Braulke T. Biochem. J. 2003; 376: 369-376Crossref PubMed Scopus (29) Google Scholar). BHK21 cells were with in and for at and with and at the indicated The proteins were by Braulke T. J. Biol. Chem. Full Text PDF PubMed Google Scholar, P. C. C. A. R. Braulke T. Mol. Biol. Cell. 1997; 8: PubMed Scopus (35) Google Scholar). were using the Bradford protein with as a were with as described J.L. 22: PubMed Scopus (29) Google Scholar). BHK21 were and in the presence or of 1 of peptide N-glycosidase or of endoglycosidase H, to the The were by followed by immunofluorescence was with BHK21 cells as described C. Tyynelä J. Cooper J.D. Palmer D.N. Elleder M. Kohlschütter A. Braulke T. Biochem. J. 2003; 376: 369-376Crossref PubMed Scopus (29) Google Scholar) using or antibodies as and were as described H. Proc. Natl. Acad. Sci. U. S. A. 62: PubMed Scopus Google Scholar, Figura K. Exp. Cell PubMed Scopus Google Scholar). of and CLN6 and CLN6 were expressed in BHK21 cells. and BHK21 cells were used as controls. analysis using the peptide-specific revealed a of in cell of cells material was in cells with the vector of was observed in cells the of the nitrocellulose membrane and with the CLN6 was CLN6 an ER-resident deduced amino acid sequence and the predicted protein of CLN6 revealed neither N-glycosylation amino nor classical lysosomal sorting the other the sequence has been in the ER membrane protein B. B. R. C. E. 2003; PubMed Scopus Google Scholar), whereas the of CLN6 by 1 has been to function as a putative targeting signal for H. Boustany R.M. Espinola J.A. Cotman S.L. Srinidhi L. Antonellis K.A. Gillis T. Qin X. Liu S. Donahue L.R. Bronson R.T. Faust J.R. Stout D. Haines J.L. Lerner T.J. MacDonald M.E. Am. J. Hum. Genet. 2002; 70: 324-335Abstract Full Text Full Text PDF PubMed Scopus (174) Google Scholar). investigate its subcellular an N-glycosylation was in the predicted was for a by of the CLN6 cDNA the sequence to the was expressed in BHK21 analysis revealed an of which after with PNGase or endo These data that the CLN6 been to the of the ER and to the glycosylation was confirmed by double immunofluorescence The protein with the ER marker protein but not with the lysosomal marker enzyme cathepsin D CLN6 of CLN6 to form in was examined by BHK21 cells CLN6 were with the reagents or analysis that the of a after in a whereas the of the CLN6 These indicate that CLN6 partially as a in CLN6 and of Newly CLN6 is for the transport and processing of lysosomal the and proteolytic of synthesized was in fibroblasts from CLN6 patients, nclf and the cells. In human is synthesized as a form A. J. Biol. Chem. Full Text PDF PubMed Google Scholar). A of the this of is secreted The of the protein to MPRs in the trans-Golgi network and is transported to is to the form after V. R. A. von Figura K. J. Cell Biol. PubMed Scopus Google Scholar). The forms are delivered to lysosomes and are to the and forms after South Hampshire sheep fibroblasts were for 1 with a was with the a of and of the were as a form from cells and as a form from the respectively labeling of mouse fibroblasts followed by immunoprecipitation with the a was observed S. S. A. Tyynelä J. Braulke T. Biochem. J. 2003; PubMed Scopus Google Scholar). of synthesized were as a in the a of These that the sorting and processing of synthesized was not affected in fibroblasts from a CLN6 from or from nclf mice. the of other lysosomal enzymes, and ASA, were in and and mouse CLN6-defective cells. of A in CLN6-defective CLN6 affect the endocytic pathway to the fibroblasts from CLN6 patients, nclf and the were with for Because the MPR46 does not function in of lysosomal enzymes M. J.E. H. A. von Figura K. EMBO J. PubMed Scopus Google Scholar), the of is mediated by the The is as shown by the in the presence of an of Man-6-P The of of experiments that the of in human CLN6, OCL6, and nclf cells is and in cells. is for the the of are in and CLN6-defective cells The intracellular of in CLN6-defective cells result from an of of caused by elevated of at the cell surface or of or degradation of endocytosed The of at the cell surface of and sheep fibroblasts was shown to be the was on the and affected sheep fibroblasts most in intracellular after by cell surface followed by immunoprecipitation of and analysis in these the of at the cell surface of and fibroblasts were that the of intracellular in cells is not the result of of at the cell The of the was shown by the of MESNA, which the the degradation of endocytosed was in CLN6-defective cells were with of the the cells were or for a The cells were by and of the revealed that the of intracellular in cells from CLN6 patients was in cells after of the of the intracellular in cells was reduced to whereas in fibroblasts from CLN6 These data indicate that the degradation of endocytosed is strongly in CLN6-defective cells. In the study, we have examined the subcellular localization of the CLN6 protein. in the CLN6 gene the accumulation of storage material in lysosomes and the clinical of the variant late infantile neuronal ceroid we that CLN6 is an ER-resident protein of dimers. Furthermore, neither the synthesis, the nor the transport of synthesized CtsD, a lysosomal was in CLN6-defective whereas the degradation of an was lines of the translocation and localization of the CLN6 protein to the the CLN6 sites were to with PDI, an ER but not with the cis-Golgi marker or with lysosomes for the CLN6 protein does not undergo proteolytic processing contains no N-glycosylation the of the by in the acid in the of an that be by PNGase The mutant CLN6 was also to endo the mannose but not These data strongly the of CLN6 in the ER of membrane proteins is by signal and targeting motifs the transmembrane proteins a in the whereas an signal as targeting signal in membrane proteins B. B. R. C. E. 2003; PubMed Scopus Google Scholar, EMBO J. PubMed Scopus Google Scholar, P. F. Cell Biol. 1997; 9: PubMed Scopus Google Scholar). have revealed ER signals as a or M. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar, J.M. J. J. 2003; 23: PubMed Google Scholar, Zhang C. J. 2001; 21: PubMed Google Scholar). Furthermore, the of proteins mediated by transmembrane or protein complexes into transport and from the ER EMBO J. PubMed Scopus Google Scholar, J. M. J.D. M. Cell 2003; PubMed Scopus Google Scholar, J.M. J. J. Biol. Chem. 2003; Full Text Full Text PDF PubMed Scopus Google Scholar). The signal for the of the polytopic CLN6 in the ER are not known. the and the and However, the of these motifs by and not the ER localization of the mutant and S. is also that the in this or the of CLN6 in complexes its from the The function of CLN6 has not been However, the of synthesis, and proteolytic processing of in CLN6-defective and cells as as of lysosomal enzymes, and ASA, suggest that CLN6 does not transport of at enzymes to the lysosome. the other this that the to arylsulfatase A is in CLN6-defective cells. the of the synthesized has been to be F. A. von Figura K. J. Biochem. 1985; PubMed Scopus Google Scholar), the human is F. A. von Figura K. J. Biochem. 1985; PubMed Scopus (16) Google and the is that the be by endocytosed in lysosomal R. Schmidt B. Dierks T. K. E. I. von Figura K. J. Biol. Chem. 2002; 277: Full Text Full Text PDF PubMed Scopus (33) Google Scholar). the endocytosed as an index for the degradation in CLN6-defective the indicate that lysosomal are or other lysosomal as or the presence of are is of that the of cells with protein the in disease, to an expression of of lysosomal The data suggest that the lysosomal is W. S. J. 2003; PubMed Scopus Google Scholar). to a ER-resident membrane protein is not CLN8 is polytopic ER membrane protein in progressive with mental to the group of NCL (16Lonka L. Kyttälä A. Ranta S. Jalanko A. Lehesjoki A.-E. Hum. Mol. Genet. 2000; 9: 1691-1697Crossref PubMed Scopus (96) Google Scholar). to be the reduced for lysosomal degradation of proteins demonstrated in this is for CLN6 or in both and cells.
49
A Trafficking Checkpoint Controls GABAB Receptor Heterodimerization
Marta Margeta, Yuh Nung Jan, Lily Yeh Jan · Neuron · 2000 · 674 citations · Full text